Cellares and Papillon partner for PPL-001 manufacturing automation

​

Cellares and Papillon Therapeutics have entered into a partnership to automate the manufacturing of PPL-001, an investigational therapy developed by the latter for FA, a rare inherited neurodegenerative disorder.

The post Cellares and Papillon partner for PPL-001 manufacturing automation appeared first on Hospital Management.

 

Back to the Featured Stories
Cellares and Papillon partner for PPL-001 manufacturing automation

Featured Stories

Philips secures FDA clearance for SpO₂ clip sensor
Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval
ARUP introduces spectral flow assay for multiple myeloma
Akagera announces positive Phase I data of AKG-100 in tuberculosis
Halozyme and Incyte sign licence agreement for INCA033989 formulations

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us